Efficacy of the Consilium Smartphone App for Detecting Symptoms and Treatment Side Effects in Cancer Patients (APP-2)
Efficacy of the Consilium Smartphone App for Detecting Symptoms and Treatment Side Effects in Cancer Patients Depending on Form of Medication Application, Age and Outpatient Characteristics: Observational Study
Sponsor: OnkoZentrum Zürich AG
Terminated
Mainly due to insufficient recruitment
A observational or N/A phase clinical study on Telemedicine and eHealth, this trial is terminated or withdrawn. The trial is conducted by OnkoZentrum Zürich AG and has accumulated 11 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Terminated
-
Sep 2024 — Sep 2025 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Apr 2022 — Jul 2024 [monthly]
Terminated
-
Feb 2022 — Apr 2022 [monthly]
Terminated
▶ Show 6 earlier versions
-
Jan 2021 — Feb 2022 [monthly]
Terminated
-
Dec 2020 — Jan 2021 [monthly]
Terminated
Status: Recruiting → Terminated
-
Sep 2020 — Dec 2020 [monthly]
Recruiting
-
Apr 2020 — Sep 2020 [monthly]
Recruiting
-
Oct 2019 — Apr 2020 [monthly]
Recruiting
-
Aug 2018 — Oct 2019 [monthly]
Recruiting
First recorded
Mar 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- OnkoZentrum Zürich AG
- Stiftung Swiss Tumor Institute
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aarau, Switzerland , Bern, Switzerland , Bülach, Switzerland , Cham, Switzerland , Feldkirch, Austria , Halle, Germany , Liestal, Switzerland , Lübeck, Germany , Offenbach, Germany , Schlieren, Switzerland and 1 more location